NASDAQ:RETA Investor Alert: Lawsuit Alleges Securities Laws Violations by Reata Pharmaceuticals, Inc
An investor, who purchased shares of Reata Pharmaceuticals, Inc. (NASDAQ:RETA), filed a lawsuit over alleged violations of Federal Securities Laws by Reata Pharmaceuticals, Inc.
View full press release